NFKB1 and cancer: Thus, the modulation of NFκB activity represents an useful therapeutic strategy for cancer, since NFκB inhibition promotes apoptotic events induced by chemotherapy, reduces the high proliferative rate that characterizes tumor cells and inhibits metastasis [13].